Incidence Rate of Otitis Externa Episodes in Atopic Dogs Is Reduced by a Therapeutic Diet in a 6‐Month Randomised, Blinded, Controlled, Clinical Trial
Veterinary Dermatology · 2026
DOI: 10.1111/vde.70017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Dermatology, 2026. Verfasst von Adrian Watson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Royal Canin SAS, Research and Development, Aimargues, France. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Diet, Dog Diseases, Otitis Externa. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Royal Canin.
Abstract (Originalsprache)
Background
Recurrent otitis externa (OE) episodes commonly affect dogs with canine atopic dermatitis (cAD) despite ongoing cAD treatment.
Objective
To determine if a therapeutic diet with active ingredients targeting the skin barrier and allergy pathways reduces the incidence rate of OE. Animals, Materials and Methods Thirty‐four client‐owned dogs with active erythroceruminous OE + cAD (not necessarily active) were randomised to test ( n = 16) or control diet ( n = 18), fed for up to 6 months. Dogs had to be in remission by Month (M)1 after initial OE treatment. Outcomes included incidence rate (percentage of dogs with ≥ 1 OE episode), 0–3 Otitis Index Score (OTIS‐3), cAD Extent and Severity Index, 4th iteration (CADESI‐04), and medication score (medication required to control OE and/or cAD) at M3 and the end‐point, defined as each dog's last on‐study data.
Results
The incidence rate was significantly lower in the test versus control group (25% vs. 61%, p < 0.01). OTIS‐3 and CADESI‐04 improved significantly between baseline and M3 in both groups (control: p = 0.003 and p < 0.001; test: each p = 0.001). Between M3 and the end‐point, OTIS‐3 and CADESI‐04 rebounded significantly in the control ( p = 0.025 and p = 0.026) and not in the test group ( p = 0.139 and p = 0.909). CADESI improvement from baseline was maintained at the end‐point in the test ( p < 0.001) and not in the control group ( p = 0.227). Medication score improved significantly throughout the diet duration in the test group (baseline to M3, M3 to end‐point, and baseline to end‐point) versus no improvements in the control group. Conclusion and Clinical Relevance A therapeutic diet for cAD helped to sustain improvements in aural manifestations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Royal Canin SAS, Research and Development, Aimargues, France.
- Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zürich, Zürich, Switzerland.
- Clinical Veterinary Medicine, Department of Clinical Dermatology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
ORCID-Profile: Adrian Watson, Franco Martini, Nina Fischer, Elisa Maina, Claude Favrot
Förderung
- Royal Canin
Zitieren
APA
Watson, A., Laxalde, J., Martini, F., Fischer, N., Maina, E., & Favrot, C. (2026). Incidence Rate of Otitis Externa Episodes in Atopic Dogs Is Reduced by a Therapeutic Diet in a 6‐Month Randomised, Blinded, Controlled, Clinical Trial. Veterinary Dermatology. https://doi.org/10.1111/vde.70017
Vancouver
Watson A, Laxalde J, Martini F, Fischer N, Maina E, Favrot C. Incidence Rate of Otitis Externa Episodes in Atopic Dogs Is Reduced by a Therapeutic Diet in a 6‐Month Randomised, Blinded, Controlled, Clinical Trial. Veterinary Dermatology. 2026. doi:10.1111/vde.70017
BibTeX
@article{Watson2026,
author = {Watson, Adrian and Laxalde, Jeremy and Martini, Franco and Fischer, Nina and Maina, Elisa and Favrot, Claude},
title = {Incidence Rate of Otitis Externa Episodes in Atopic Dogs Is Reduced by a Therapeutic Diet in a 6‐Month Randomised, Blinded, Controlled, Clinical Trial},
journal = {Veterinary Dermatology},
year = {2026},
doi = {10.1111/vde.70017}
}
EUVIMED